We tested this hypothesis in two different mouse models for RP, the rd1 and the Rho−/− mouse, by targeted deletion of the gene coding for Cx36, the gap junction-forming protein on the cone side. The gene discussed is RHO; the disease is retinitis pigmentosa 1.